A federal judge has ordered Martin Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life.
Former pharmaceutical executive Martin Shkreli smiles while speaking to the media in front of U.S. District Court for the Eastern District of New York with members of his legal team after the jury issued a verdict, August 4, 2017 in the Brooklyn boroMartin Shkreli must return $64.
He defended the decision as capitalism at work and said insurance and other programs ensured that people who need Daraprim would ultimately get it. Shkreli eventually offered hospitals half off — still amounting to a 2,500% increase. But patients normally take most of the weekslong treatment after returning home, so they and their insurers still faced the $750-a-pill price.
They alleged that Vyera hiked the price of Daraprim and illegally created "a web of anticompetitive restrictions" to prevent other companies from creating cheaper generic versions by, among other things, blocking their access to a key ingredient for the medication and to data the companies would want to evaluate the drug’s market potential.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
'Pharma Bro' Martin Shkreli ordered to pay $64 million for hiking cost of lifesaving drugNEW: A federal judge ruled that Martin Shkreli, who became infamous after he hiked the price of a potentially lifesaving antiparasitic medication in 2015, to pay $64 million—equivalent to the profits from his scheme
Lire la suite »
U.S. judge bars Martin Shkreli from drug industry, orders $64.6 million paymentWASHINGTON (Reuters) -A U.S. judge on Friday barred Martin Shkreli from the pharmaceutical industry for life and ordered him to pay $64.6 million after he famously raised the price of Daraprim and fought to block generic competitors. U.S. District Judge Denise Cote in Manhattan ruled after a trial where the U.S. Federal Trade Commission and seven states had accused Shkreli, the founder of Vyera Pharmaceuticals, of using illegal tactics to keep Daraprim rivals out of the market. Shkreli drew notoriety in 2015 after hiking Daraprim's price overnight to $750 per tablet from $17.50.
Lire la suite »
NY Attorney General Announces Martin Shkreli Ruling With Wu-Tang ReferenceLetitia James quoted the hip-hop group's 1994 song 'C.R.E.A.M.' when she said the 'pharma bro' must pay back $64 million and is banned from the industry.
Lire la suite »
Martin Shkreli Banned for Life From Drug Industry, Ordered to Pay Nearly $65 MillionMartin Shkreli, the so-called pharma bro embroiled in a drug-pricing scandal, was banned for life from the pharmaceutical industry on Friday after a federal court found that he engaged in illegal and monopolistic behavior
Lire la suite »
'Pharma bro no more': Martin Shkreli banned from pharmaceutical business for lifeDisgraced drug company executive Martin Shkreli, derided as the “Pharma Bro,” has been banned from ever doing business again in the pharmaceutical business.
Lire la suite »